Cargando…

Cost-effectiveness of dolutegravir vs. efavirenz-based combined antiretroviral therapies in HIV-infected treatment-naive patients in a Nigerian treatment centre

BACKGROUND: Dolutegravir (DTG) based antiretroviral therapy (ART) has largely replaced Efavirenz (EFV) based therapy as the preferred first-line regimen in the treatment of adults with HIV. This study was carried out to evaluate the comparative cost-effectiveness of DTG and EFV-based ART in HIV-infe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isah, Abdulmuminu, Chukwu, Patrick O, Abba, Abubakar, Igboeli, Nneka U, Ebere, Ayogu, Omotola, Olusegun F, Alozie, Faith A, Ekwunife, Obinna I, Adibe, Maxwell O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Makerere Medical School 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398478/ https://www.ncbi.nlm.nih.gov/pubmed/37545946 http://dx.doi.org/10.4314/ahs.v23i1.18

Ejemplares similares

Increasing use of artemisinin-based combination therapy for treatment of malaria infection in Nigerian hospitals
por: Igboeli, Nneka U., et al.
Publicado: (2010)

A CROSS-SECTIONAL ASSESSMENT OF PHARMACISTS’ KNOWLEDGE, ATTITUDE AND PRACTICE OF PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV IN TWO NIGERIAN TEACHING HOSPITALS
por: Abdulmuminu, Isah, et al.
Publicado: (2022)

PREDICTORS OF SELF REPORTED ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN A NIGERIAN POPULATION
por: Ikechuwku, Ekwunife Obinna, et al.
Publicado: (2010)

Risk and protective factors associated with depression in young people: what do Nigerian university students know?
por: Anosike, Chibueze, et al.
Publicado: (2022)

Health state utilities of a population of Nigerian hypertensive patients
por: Ekwunife, Obinna I, et al.
Publicado: (2011)

Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
por: Anyakora, Chimezie, et al.
Publicado: (2017)

Factors associated with the timely completion of doctoral research studies in clinical pharmacy: A mixed-methods study
por: Mosanya, Adaobi U., et al.
Publicado: (2022)

Knowledge, Attitudes and Perceptions of Prostate Cancer among Male Staff of the University of Nigeria
por: Adibe, Maxwell Ogochukwu, et al.
Publicado: (2017)

Evaluation of Health Status of Type 2 Diabetes Outpatients Receiving Care in a Tertiary Hospital in Nigeria
por: Adibe, Maxwell Ogochukwu, et al.
Publicado: (2017)

Prescribing Pattern and Antibiotic Use for Hospitalized Children in a Northern Nigerian Teaching Hospital
por: Umar, Lawal Waisu, et al.
Publicado: (2018)

Prevalence of Low Birth Weight before and after Policy Change to IPTp-SP in Two Selected Hospitals in Southern Nigeria: Eleven-Year Retrospective Analyses
por: Igboeli, Nneka U., et al.
Publicado: (2018)

Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study
por: Zash, Rebecca, et al.
Publicado: (2018)

Treatment Outcomes of Dolutegravir- Versus Efavirenz-Based Highly Active Antiretroviral Therapy Regimens Among Treatment-Naive People Living With HIV
por: Mahale, Prarthana R, et al.
Publicado: (2023)

Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir
por: Song, Ivy, et al.
Publicado: (2014)

Concentration-Response Relationships of Dolutegravir and Efavirenz with Weight Change After Starting Antiretroviral Therapy
por: Griesel, Rulan, et al.
Publicado: (2022)

CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz
por: Griesel, Rulan, et al.
Publicado: (2020)

Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function
por: Huang, Chang, et al.
Publicado: (2023)

Satisfaction of Nigerian patients with health services: a protocol for a systematic review
por: Akunne, Maureen O., et al.
Publicado: (2019)

Cost benefit analysis of malaria rapid diagnostic test: the perspective of Nigerian community pharmacists
por: Ezennia, Ifeoma Jovita, et al.
Publicado: (2017)

Engaging Nigerian community pharmacists in public health programs: assessment of their knowledge, attitude and practice in Enugu metropolis
por: Offu, Ogochukwu, et al.
Publicado: (2015)

Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines
por: Phillips, Andrew N, et al.
Publicado: (2020)

The participation of community pharmacists in the case management of malaria in Enugu metropolis, Nigeria: a cross-sectional survey
por: Anosike, Chibueze, et al.
Publicado: (2020)

Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir
por: Khemla, Supphachoke, et al.
Publicado: (2023)

Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in Ethiopia
por: Belay, Yared Belete, et al.
Publicado: (2021)

A retrospective clinical study of dolutegravir- versus efavirenz-based regimen in treatment-naïve patients with advanced HIV infection in Nanjing, China
por: Zhong, Mingli, et al.
Publicado: (2023)

Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
por: Twimukye, Adelline, et al.
Publicado: (2021)

Human health hazards of poly aromatic hydrocarbons in Nigerian smokeless tobacco
por: Orisakwe, Orish Ebere, et al.
Publicado: (2015)

A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
por: Ochanda, Perez Nicholas, et al.
Publicado: (2022)

Pharmacists' Readiness to Receive, Recommend and Administer COVID-19 Vaccines in an African Country: An Online Multiple-Practice Settings Survey in Nigeria
por: Isah, Abdulmuminu, et al.
Publicado: (2021)

Suppression of HIV in the first 12 months of antiretroviral therapy: a comparative analysis of dolutegravir- and efavirenz-based regimens
por: da Silva, Gabriella Jomara, et al.
Publicado: (2023)

Student pharmacists’ career choices: a survey of three Nigerian schools of pharmacy
por: Ubaka, Chukwuemeka M., et al.
Publicado: (2013)

Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir
por: Keegan, Michael R., et al.
Publicado: (2018)

Effects of nutritional supplements on the re-infection rate of soil-transmitted helminths in school-age children: A systematic review and meta-analysis
por: Isah, Aisha Ummi Jibrin, et al.
Publicado: (2020)

Ulcerative Colitis Prone to Delayed Diagnosis in a Nigerian Population: Case Series
por: Ekwunife, CN, et al.
Publicado: (2015)

Dolutegravir plus lamivudine versus efavirenz plus tenofovir disoproxil fumarate and lamivudine in antiretroviral-naive adults with HIV-1 infection
por: Deng, Lisi, et al.
Publicado: (2022)

Components and Risk Factors of Metabolic Syndrome among Rural Nigerian Workers
por: Ayogu, Rufina N. B., et al.
Publicado: (2019)

Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial)
por: Bousmah, Marwân-al-Qays, et al.
Publicado: (2020)

Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis
por: Kanters, Steve, et al.
Publicado: (2020)

Physiologically Relevant Concentrations of Dolutegravir, Emtricitabine, and Efavirenz Induce Distinct Metabolic Alterations in HeLa Epithelial and BV2 Microglial Cells
por: George, Joseph W., et al.
Publicado: (2021)

Immunological, Cognitive, and Psychiatric Outcomes After Initiating Efavirenz- and Dolutegravir-based Antiretroviral Therapy During Acute Human Immunodeficiency Virus Infection
por: Chan, Phillip, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nkegugccbhd0boajs309mtqoh7